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0.9 or less. An ABI of >1.4 was defined as a non-compressible vessel. Clinical PAD was identified by self-report, review of medical records for other events or as review of Center for Medicaid Services (CMS) records for the ICD-9 codes 440.2 and 443.9 and adjudicated by the cardiac subgroup of the CHS Clinical Events Subcommittee. Detailed criteria for the diagnosis of clinical PAD have already been described. 3 Follow-up data for clinical PAD were available by June 2015.
Individuals who did not attend the Year 9 visit (n = 1475), had prevalent clinical PAD at Year 9 (n = 106) or were missing CML measurement (n = 1040) were excluded from the analysis. In addition, those without ABI measurement or with non-compressible vessels were excluded from the low ABI analysis (n = 984). Logistic regression modelling was performed to investigate the associations of baseline CML levels with low ABI at Year 11. Cox proportional hazards models were used to determine the association of baseline CML levels with incident PAD. In these analyses, CML was modelled continuously [per 1 standard deviation (SD) increment] and also categorized into quartiles. Models were adjusted for age, sex, race, clinic site, total cholesterol, myocardial infarction, stroke, heart failure, anti-hypertension medication use, systolic blood pressure, cigarette smoking status and pack-years, diabetes medication use, glucose, physical activity, statin use, estimated glomerular filtration rate, albumin and C-reactive protein.
Mean age for the included participants was 78.0 years, 39% were male and 16% were black. There were 417 (17.2%) participants found to have a low ABI at Year 11. Over a median follow-up of 10.0 years, 157 (4.8%) participants developed clinical PAD. No significant relationship between CML levels and risk of either prevalent low ABI or incident clinical PAD was found (Table 1) .
In a large community-based cohort of older adults, we found no association of CML levels with either an increased risk of low ABI or incident clinical PAD in multivariate adjusted models. Current literature regarding associations of CML and PAD were limited to small casecontrol studies that measured tissue AGE with skin autofluorescence, showing higher levels in those with PAD compared to those without. 4 Atherosclerosis is a complex process that demonstrates heterogeneity in different-sized vascular beds. Significant differences in the strength of the association of traditional cardiovascular risk factors such as diabetes or cigarette smoking with PAD versus other forms of atherosclerotic disease have already been established. 5 It is possible, therefore, that the relationship of CML with the larger vessels of the lower extremities may differ from its relationship with other smaller arterial vessels located in the coronary or cerebral vasculature. In addition, it is also possible that the relationship of CML in the development of PAD may also differ with age and that a role for this AGE may exist in younger individuals. Participants in this cohort have had over 70 years to develop PAD through multiple pathways and elevated CML levels found later in life may not be significant enough to make a difference. This study has limitations. Eligibility for this analysis required that participants should be healthy enough to attend the Year 9 visit and have CML measured at this time. ABI examination was not performed at the same time of CML measurement.
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